NO20023761L - Selektiv N-acylering av A82846 glykopeptidanaloger - Google Patents

Selektiv N-acylering av A82846 glykopeptidanaloger

Info

Publication number
NO20023761L
NO20023761L NO20023761A NO20023761A NO20023761L NO 20023761 L NO20023761 L NO 20023761L NO 20023761 A NO20023761 A NO 20023761A NO 20023761 A NO20023761 A NO 20023761A NO 20023761 L NO20023761 L NO 20023761L
Authority
NO
Norway
Prior art keywords
acylation
selective
glycopeptide
glycopeptide analogs
analogs
Prior art date
Application number
NO20023761A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023761D0 (no
Inventor
Richard Craig Thompson
Stephen Charles Wilkie
Mark James Zweifel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20023761D0 publication Critical patent/NO20023761D0/no
Publication of NO20023761L publication Critical patent/NO20023761L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO20023761A 2000-02-11 2002-08-08 Selektiv N-acylering av A82846 glykopeptidanaloger NO20023761L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18168300P 2000-02-11 2000-02-11
PCT/US2001/004540 WO2001058933A2 (en) 2000-02-11 2001-02-12 Selective n-acylation of a82846 glycopeptide analogs

Publications (2)

Publication Number Publication Date
NO20023761D0 NO20023761D0 (no) 2002-08-08
NO20023761L true NO20023761L (no) 2002-08-26

Family

ID=22665319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023761A NO20023761L (no) 2000-02-11 2002-08-08 Selektiv N-acylering av A82846 glykopeptidanaloger

Country Status (18)

Country Link
US (1) US7365053B2 (de)
EP (1) EP1254164B1 (de)
JP (1) JP2003522197A (de)
KR (1) KR100796079B1 (de)
CN (1) CN1422279A (de)
AT (1) ATE308560T1 (de)
AU (2) AU3818001A (de)
BR (1) BR0108268A (de)
CA (1) CA2399640A1 (de)
CZ (1) CZ20022722A3 (de)
DE (1) DE60114567T2 (de)
HK (1) HK1049171A1 (de)
MX (1) MXPA02007739A (de)
NO (1) NO20023761L (de)
NZ (1) NZ520482A (de)
PL (1) PL356966A1 (de)
WO (1) WO2001058933A2 (de)
ZA (1) ZA200206360B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003260198A1 (en) * 2002-08-30 2004-03-19 Chiron Corporation Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents
US8088387B2 (en) * 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
CN1557479A (zh) * 2004-01-16 2004-12-29 深圳市海王英特龙生物技术股份有限公 干扰素脂质体乳膏
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
AU2018271873B2 (en) 2017-05-22 2023-11-02 Insmed Incorporated Glycopeptide derivative compounds and uses thereof
CN108484719A (zh) * 2018-01-19 2018-09-04 四川大学 硫酸酯化十二指肠糖肽制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4639433A (en) * 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
ZA909847B (en) * 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
CA2330619A1 (en) * 1998-05-01 1999-11-11 Eli Lilly And Company N1-modified glycopeptides

Also Published As

Publication number Publication date
AU2001238180B2 (en) 2005-12-15
CN1422279A (zh) 2003-06-04
ATE308560T1 (de) 2005-11-15
JP2003522197A (ja) 2003-07-22
AU2001238180B8 (en) 2006-07-27
KR100796079B1 (ko) 2008-01-21
EP1254164A2 (de) 2002-11-06
PL356966A1 (en) 2004-07-12
AU3818001A (en) 2001-08-20
CA2399640A1 (en) 2001-08-16
NZ520482A (en) 2004-12-24
BR0108268A (pt) 2003-03-05
WO2001058933A3 (en) 2002-02-14
US20070219123A1 (en) 2007-09-20
MXPA02007739A (es) 2002-10-11
DE60114567D1 (de) 2005-12-08
NO20023761D0 (no) 2002-08-08
HK1049171A1 (en) 2003-05-02
DE60114567T2 (de) 2006-07-27
CZ20022722A3 (cs) 2003-01-15
KR20020073546A (ko) 2002-09-26
US7365053B2 (en) 2008-04-29
ZA200206360B (en) 2003-11-10
EP1254164B1 (de) 2005-11-02
WO2001058933A2 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
DE60223836D1 (de) System für bi-ventrikuläres gleichzeitiges schrittmachen
DE60221289D1 (de) Zuführsystem für medizinische vorrichtungen
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
BR0207291B1 (pt) conduto flexìvel.
DE60227557D1 (de) Suszeptor für das epitaxiale wachstum
DE60237967D1 (de) Abdichtungsvorrichtung zur herstellung weicher artikel mitabgedichteten bereichen
DE60234939D1 (de) Stent für die eustachische röhre
DE60104179D1 (de) Chirurgisches Gerät für den Glaskörper
DE60134335D1 (de) Sondierungssystem für schallquellen
EA200601029A1 (ru) Способ очистки фсг
CY1107759T1 (el) Λυοφιλισμενη συνταγοποιηση που περιλαμβανει ολανζαπινη
CY1105980T1 (el) Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου
CR8167A (es) Procedimiento para la preparacion de derivados de espirobenzoacepina sustituida no peptidica
NO20023761D0 (no) Selektiv N-acylering av A82846 glykopeptidanaloger
DK1392722T3 (da) Fremgangsmåde vedrörende echinocandiner
ATE361931T1 (de) N1 modifizierte glycopeptide
NO20025264L (no) Reduktiv alkyleringsprosess
IT1319682B1 (it) Procedimento di sintesi del paclitaxel.
DE60202023D1 (de) Dichtungsanlage für Verdichter
DE50212676D1 (de) Exopolysaccharidproduktion
IT247344Y1 (it) Rubinetto per gas valvolato.
DE50214530D1 (de) Verfahren für den Brieftaubensport
DK1390056T3 (da) Glycopeptid-antibiotika